6
Oct
2026
Ascendia Pharmaceuticals
About Ascendia Pharmaceuticals
Certifications
-
GMP -
ISO
Categories
Meet us at
-
CPHI Milan 2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026stand 12P34
-
Country/Region:United States
-
Founded:2012
-
On CPHI since:2017
-
Certificates:2
-
Employees:50 - 99
Company types
Primary activities
Contact info
-
-
-
661 US-1, 08902, North Brunswick Township, New Jersey, United States
Products from Ascendia Pharmaceuticals (18)
-
Product AmorSol®
Ascendia Pharmaceutical Solutions offers its AmorSol® platform: a technology for the production of amorphous solid dispersions. Solid dispersions are used to increase the dissolution rate, a limiting factor for the absorption of many compounds in development today. Contact us for more information. -
Product cGMP clinical batches of injectable dosage forms
Ascendia pharmaceuticals offers cGMP clinical batches of injectable dosage forms. Features: a dedicated, self-contained cleanroom for conducting sterile manufacturing and fill processes is maintained. Contact us for more information. -
Product cGMP clinical batches of tablet and capsule dosage forms
Ascendia pharmaceuticals offers cGMP clinical batches of tablet and capsule dosage forms. Features: it require capability to granulate, blend, and roller compact to make tablet batches for immediate release and modified release applications. Contact us for more information. -
Product EmulSol®
Ascendia Pharmaceutical Solutions offers its EmulSol® platform: a technology for production of oil-in-water nano-emulsions. Nano-emulsions are meta-stable and a high level of input energy is required to produce a nano-emulsion. Contact us for more information. -
Product Lyophilization
Ascendia pharmaceuticals offers lyophilization. Features: it is an equipment for producing pharmaceutical formulations. Contact us for more information. -
Product Micro-fluidizer
Ascendia pharmaceuticals offers micro-fluidizer. Features: it is an equipment for producing pharmaceutical formulations. Contact us for more information. -
Product Nano-particle bead-milling
Ascendia pharmaceuticals offers nano-particle bead-milling. Features: it is an equipment for producing pharmaceutical formulations. Contact us for more information. -
Product Nanosol
Ascendia pharmaceuticals offers nanosol. Features: it is a technology for the production of nano-sized drug particles. Formulation of a drug substance in nano-particle form significantly increases the surface area available for dissolution. Contact us for more information. -
Product NanoSol®
NanoSol® is Ascendia's technology platform for the production of nano-sized drug particles. Formulation of a drug substance in nanoparticle form significantly increases the surface area available for dissolution. A 10-to-20-fold increase in surface area can result from reducing particle size from a m... -
Product Nmr and xrpd
Ascendia pharmaceuticals offers nmr and xrpd. Features: it is an analytical instrument for testing pharmaceutical formulations. Contact us for more information. -
Product Particle size distribution analysis
Ascendia pharmaceuticals offers particle size distribution analysis. Features: it is an analytical instrument for testing pharmaceutical formulations. Contact us for more information. -
Product Roller compaction
Ascendia pharmaceuticals offers roller compaction. Features: it is an equipment for producing pharmaceutical formulations. Contact us for more information.
Ascendia Pharmaceuticals Resources (1)
-
Whitepaper Drug Formulation Development Process Notes From A CDMO
Pharma R&D productivity has remained stagnant in the new millennium, despite record industry growth. While new technology has improved productivity in nearly every other sector, efficiency in pharmaceutical R&D is declining (or as described by MedCity News — “broken”).What obstacles are in the way of improving productivity in the pharmaceutical industry? How can we meet these challenges? At Ascendia Pharma, we’re proud to have innovative strategies in place to help our clients get their drugs from R&D to market faster.